Inspire Medical Systems, Inc. (INSP)
USD 149.7
(1.46%)
USD 149.7
(1.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 676.81 Million USD | 19.82% |
| 2022 | 564.87 Million USD | 91.43% |
| 2021 | 295.08 Million USD | 4.94% |
| 2020 | 281.18 Million USD | 55.14% |
| 2019 | 181.25 Million USD | -9.41% |
| 2018 | 200.08 Million USD | 697.42% |
| 2017 | 25.09 Million USD | 91.3% |
| 2016 | 13.11 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 685.84 Million USD | 1.33% |
| 2024 Q2 | 728.38 Million USD | 6.2% |
| 2024 Q3 | 796.19 Million USD | 9.31% |
| 2023 FY | 676.81 Million USD | 19.82% |
| 2023 Q3 | 639.49 Million USD | 3.44% |
| 2023 Q2 | 618.24 Million USD | 8.11% |
| 2023 Q1 | 571.84 Million USD | 1.23% |
| 2023 Q4 | 676.81 Million USD | 5.84% |
| 2022 Q1 | 289.72 Million USD | -1.82% |
| 2022 Q4 | 564.87 Million USD | 7.08% |
| 2022 FY | 564.87 Million USD | 91.43% |
| 2022 Q3 | 527.52 Million USD | 80.66% |
| 2022 Q2 | 292 Million USD | 0.79% |
| 2021 Q1 | 273.41 Million USD | -2.77% |
| 2021 FY | 295.08 Million USD | 4.94% |
| 2021 Q4 | 295.08 Million USD | 5.81% |
| 2021 Q3 | 278.89 Million USD | 2.46% |
| 2021 Q2 | 272.2 Million USD | -0.44% |
| 2020 Q4 | 281.18 Million USD | 3.46% |
| 2020 Q1 | 165.73 Million USD | -8.56% |
| 2020 FY | 281.18 Million USD | 55.14% |
| 2020 Q2 | 271.3 Million USD | 63.7% |
| 2020 Q3 | 271.78 Million USD | 0.18% |
| 2019 Q1 | 189.6 Million USD | -5.23% |
| 2019 FY | 181.25 Million USD | -9.41% |
| 2019 Q4 | 181.25 Million USD | -1.08% |
| 2019 Q3 | 183.22 Million USD | -1.26% |
| 2019 Q2 | 185.56 Million USD | -2.13% |
| 2018 Q3 | 130.72 Million USD | -2.37% |
| 2018 FY | 200.08 Million USD | 697.42% |
| 2018 Q2 | 133.89 Million USD | 380.7% |
| 2018 Q1 | 27.85 Million USD | 11.01% |
| 2018 Q4 | 200.08 Million USD | 53.06% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 25.09 Million USD | 0.0% |
| 2017 FY | 25.09 Million USD | 91.3% |
| 2016 FY | 13.11 Million USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 99.076% |
| Allurion Technologies Inc. | 71.71 Million USD | -843.79% |
| Artivion, Inc. | 792.39 Million USD | 14.587% |
| Avanos Medical, Inc. | 1.69 Billion USD | 60.009% |
| Butterfly Network, Inc. | 304.27 Million USD | -122.435% |
| Butterfly Network, Inc. | 304.27 Million USD | -122.435% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 94.497% |
| Boston Scientific Corporation | 35.13 Billion USD | 98.074% |
| CONMED Corporation | 2.3 Billion USD | 70.574% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | 92.772% |
| Paragon 28, Inc. | 340.69 Million USD | -98.654% |
| Glaukos Corporation | 940.41 Million USD | 28.031% |
| Globus Medical, Inc. | 5.08 Billion USD | 86.693% |
| Integer Holdings Corporation | 2.94 Billion USD | 77.0% |
| Medtronic plc | 89.98 Billion USD | 99.248% |
| Myomo, Inc. | 14.58 Million USD | -4541.552% |
| Nevro Corp. | 635.71 Million USD | -6.465% |
| Owlet, Inc. | 44.12 Million USD | -1433.919% |
| Penumbra, Inc. | 1.55 Billion USD | 56.512% |
| Vicarious Surgical Inc. | 119.86 Million USD | -464.649% |
| Smith & Nephew plc | 9.98 Billion USD | 93.223% |
| Sonendo, Inc. | 78.16 Million USD | -765.93% |
| STERIS plc | 11.06 Billion USD | 93.883% |
| Stryker Corporation | 39.91 Billion USD | 98.304% |
| Vapotherm, Inc. | 77.61 Million USD | -771.988% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 96.852% |